Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Wukun Liu

Showing results (1-10 of 71) with videos related to

Pageof 8
Sort By:
Journal of Medicinal Chemistry|November 3, 2020
Selective Estrogen Receptor Degraders (SERDs): A Promising Strategy for Estrogen Receptor Positive Endocrine-Resistant Breast CancerYunlong Lu, Wukun Liu
Chemical Society Reviews|November 14, 2012
Metal N-heterocyclic carbene complexes as potential antitumor metallodrugsWukun Liu, Ronald Gust
Archiv Der Pharmazie|April 3, 2012
Synthesis, antitumor, and antibacterial activity of bis[4,5-diarylimidazol-2-ylidene]methane derivativesWukun Liu, Xiaohua Chen, Ronald Gust
Journal of Medicinal Chemistry|April 10, 2019
Targeting the Thioredoxin System as a Strategy for Cancer TherapyMianli Bian, Rong Fan, Sai Zhao, et al.
European Journal of Medicinal Chemistry|March 28, 2020
Synthesis and biological evaluation of gold(III) Schiff base complexes for the treatment of hepatocellular carcinoma through attenuating TrxR activityMianli Bian, Xin Wang, Ying Sun, et al.
European Journal of Medicinal Chemistry|October 3, 2019
A new rhodium(I) NHC complex inhibits TrxR: In vitro cytotoxicity and in vivo hepatocellular carcinoma suppressionRong Fan, Mianli Bian, Lihong Hu, et al.
Journal of Medicinal Chemistry|January 6, 2025
Targeting KAT6A/B as a New Therapeutic Strategy for Cancer TherapyTianpeng Zheng, Shanglong Wang, Wukun Liu, et al.
European Journal of Medicinal Chemistry|April 27, 2012
Synthesis, characterization and in vitro antitumour activity of a series of novel platinum(II) complexes bearing Schiff base ligandsMaria Proetto, Wukun Liu, Adelheid Hagenbach, et al.
Medicinal Research Reviews|January 27, 2024
Metal complexes bearing EGFR-inhibiting ligands as promising anticancer agentsXiaoyan Ma, Zhaoran Wang, Yifei Li, et al.
Journal of Medicinal Chemistry|June 10, 2026
Gold(I)-Loaded Nanomedicine for Liver Cancer: A Closed-Loop Strategy Integrating Ferritinophagy-Driven Ferroptosis and ImmunotherapyYejin Zhu, Yifei Li, Yuming Jiang, et al.
Pageof 8

Showing results (1-10 of 71) with videos related to

Sort By:
Pageof 8
Journal of Medicinal Chemistry|November 3, 2020
Selective Estrogen Receptor Degraders (SERDs): A Promising Strategy for Estrogen Receptor Positive Endocrine-Resistant Breast CancerYunlong Lu, Wukun Liu
Chemical Society Reviews|November 14, 2012
Metal N-heterocyclic carbene complexes as potential antitumor metallodrugsWukun Liu, Ronald Gust
Archiv Der Pharmazie|April 3, 2012
Synthesis, antitumor, and antibacterial activity of bis[4,5-diarylimidazol-2-ylidene]methane derivativesWukun Liu, Xiaohua Chen, Ronald Gust
Journal of Medicinal Chemistry|April 10, 2019
Targeting the Thioredoxin System as a Strategy for Cancer TherapyMianli Bian, Rong Fan, Sai Zhao, et al.
European Journal of Medicinal Chemistry|March 28, 2020
Synthesis and biological evaluation of gold(III) Schiff base complexes for the treatment of hepatocellular carcinoma through attenuating TrxR activityMianli Bian, Xin Wang, Ying Sun, et al.
European Journal of Medicinal Chemistry|October 3, 2019
A new rhodium(I) NHC complex inhibits TrxR: In vitro cytotoxicity and in vivo hepatocellular carcinoma suppressionRong Fan, Mianli Bian, Lihong Hu, et al.
Journal of Medicinal Chemistry|January 6, 2025
Targeting KAT6A/B as a New Therapeutic Strategy for Cancer TherapyTianpeng Zheng, Shanglong Wang, Wukun Liu, et al.
European Journal of Medicinal Chemistry|April 27, 2012
Synthesis, characterization and in vitro antitumour activity of a series of novel platinum(II) complexes bearing Schiff base ligandsMaria Proetto, Wukun Liu, Adelheid Hagenbach, et al.
Medicinal Research Reviews|January 27, 2024
Metal complexes bearing EGFR-inhibiting ligands as promising anticancer agentsXiaoyan Ma, Zhaoran Wang, Yifei Li, et al.
Journal of Medicinal Chemistry|June 10, 2026
Gold(I)-Loaded Nanomedicine for Liver Cancer: A Closed-Loop Strategy Integrating Ferritinophagy-Driven Ferroptosis and ImmunotherapyYejin Zhu, Yifei Li, Yuming Jiang, et al.
Pageof 8